Gnb1 Gene G Protein Subunit Beta 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Parameter | Value |
|-----------|-------|
| **Gene Symbol** | GNB1 |
| **Full Name** | G Protein Subunit Beta 1 |
| **Chromosomal Location** | 1p36.33 |
| **NCBI Gene ID** | 2782 |
| **OMIM** | 139311 |
| **Ensembl ID** | ENSG00000120788 |
| **UniProt ID** | P62879 |
| **Associated Diseases** | Alzheimer's Disease, Parkinson's Disease, Epilepsy, Intellectual Disability, Cancer |
The GNB1 gene encodes the G protein subunit beta 1 (Gβ1), a key component of heterotrimeric G proteins. G proteins transduce signals from cell surface receptors to intracellular effectors, making GNB1 essential for numerous cellular processes.
GNB1/Gβ1 is part of the G protein trimer (Gαβγ):
- Signal transduction: Couples GPCR activation to downstream effectors
- Effector regulation: Modulates adenylate cyclase, phospholipase C, ion channels
- Protein interactions: Forms functional dimers with Gγ subunits
- Specificity: Different Gβ subunits confer signaling specificity
Gβγ dimers can also signal independently of Gα subunits.
- G protein signaling is impaired in AD
- Gβ1 involved in APP processing
- Synaptic G protein signaling deficits
- Dopamine receptor signaling involves Gβγ
- G protein coupling alterations in PD
- Potential for therapeutic modulation
- GNB1 mutations cause epileptic encephalopathy
- Affects GABA receptor signaling
- Developmental and seizure phenotypes
- De novo GNB1 mutations cause ID
- Developmental delay, hypotonia
- Variable phenotypes
- Gβγ signaling promotes tumor growth
- Therapeutic targeting of Gβγ
GNB1 is ubiquitously expressed:
- Brain (high)
- Heart
- Skeletal muscle
- Liver
- Kidney
In brain:
GNB1 and Gβγ signaling are therapeutic targets:
-
Gβγ Inhibitors
- Gallein
- M119
- Clinical candidates in development
-
GPCR Modulators
- Targeted drug delivery
- Allosteric modulators
-
Challenges
- Ubiquitous expression
- Multiple signaling pathways
- Smrcka AV. (2008). G protein βγ subunits: central regulators of G protein-coupled receptor signaling. Cell Mol Life Sci 65(14):2191-214.
- Khan SM, et al. (2013). Gβγ signaling in the brain. Mol Neurobiol 47(1):290-306.
- Petrov AM, et al. (2017). Gβγ and ADHD. Nat Neurosci 20(3):309-21.
GNB1 is expressed in most tissues with highest expression in:
- Brain (neurons and glial cells)
- Heart
- Skeletal muscle
- Kidney
In the brain:
- Widely expressed across brain regions
- High expression in hippocampus, cortex, and cerebellum
- Expressed in both excitatory and inhibitory neurons
- GnB1 knockout mice show embryonic lethality
- Conditional knockouts reveal learning deficits
- Zebrafish models show developmental defects
- Gβ1 isoform-specific functions
- Therapeutic targeting of Gβγ signaling
- Role in neuropsychiatric disorders
- Development of biased agonists/antagonists
GNB1 is expressed ubiquitously with highest levels in:
- Brain (neurons and glia)
- Heart and skeletal muscle
- Kidney and liver
In the brain:
- Widely distributed across all regions
- High expression in hippocampus and cerebellum
- Important for GPCR signaling
- GnB1 knockout mice show embryonic lethality
- Conditional knockouts reveal neurological phenotypes
- Zebrafish models show developmental defects
- Gβ1-specific signaling pathways
- Therapeutic targeting of Gβγ complexes
- Role in neuropsychiatric disorders
- Understanding β subunit diversity
The study of Gnb1 Gene G Protein Subunit Beta 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.